Schedule 13D ownership disclosure
Immunovant Inc
Security class unavailable · CUSIP: 45258J102
Event date: 2020-09-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 56,377,388
- Percent of class
- 57.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-20-106544
- Form type
- SC 13D
- Filer
- Immunovant, Inc.
- CIK
- CIK 1764013
- Filed
- Sep 18, 2020
- Reporting period
- Sep 17, 2020
- Description
- Schedule 13D beneficial ownership